Johnson & Johnson plans to have 100 million vaccines for Americans by spring, board member says

During remarks at the White House on Thursday, the government’s top infectious disease doctor Anthony Fauci said that Johnson & Johnson would have enough data on its vaccine to begin analysis within a week or two.
“I do know that J&J is making a very large supply, going all out with its production, both here in the U.S. and elsewhere around the world, with the goal of having perhaps enough vaccines for 100 million Americans by spring, by this April or so,” said J&J board member Dr. Mark McClellan.